Breaking: Johnson & Johnson Settles New York State Opioid Lawsuit ahead of Trial

Pharmaceutical company Johnson & Johnson has agreed to pay $230 million to New York State, ahead of a trial pertaining to the opioid crisis set to begin on Tuesday, the Wall Street Journal reported.

The deal will keep Johnson & Johnson out of the trial in New York, which includes other makers of opioid prescription drugs, but will not remove the company from trials scheduled in other states. Most U.S. states and over 3,000 counties, cities, and local governments have filed suit against drug makers in the wake of the crisis, including AmerisourceBergen, Cardinal Health Inc., and McKessen Corp.

THIS BREAKING NEWS ITEM IS PRESENTED BY

2nd-vote-advisors-logo.jpg

Breaking-News2.png
hero news image

Johnson & Johnson Settles New York State Opioid Lawsuit ahead of Trial

The deal will keep J&J out of the trial in New York, which includes other makers of opioid prescription ... READ MORE

ADVERTISEMENT

570_2VA-NR-breaking_news_01copy_disclaimer.jpg
national review

Follow Us & Share

19 West 44th Street, Suite 1701, New York, NY, 10036, USA
Your Preferences | Unsubscribe | Privacy
View this e-mail in your browser.

Comments

Popular posts from this blog

FOLLOW THE MONEY - Billionaire tied to Epstein scandal funneled large donations to Ramaswamy & Democrats

Breaking: Left-Wing Black History Children’s Book Distributed by Simon & Schuster Is Heavily Plagiarized

Adam Schiff & Gavin Newsom are about to get vetted by Peter Schweizer…